EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes

Reduktion von Hospitalisierungen und multiresistenten Organismen durch regionale Dekolonisation in Krankenhäusern und Pflegeheimen

Gabrielle M Gussin, James A McKinnell, Raveena D Singh, Loren G Miller, Ken Kleinman, Raheeb Saavedra, Thomas Tjoa, Shruti K Gohil, Tabitha D Catuna, Lauren T Heim, Justin Chang, Marlene Estevez und 27 weitere

JAMA · 14.05.2024 · 331 (18) · 1544

DOI: 10.1001/jama.2024.2759 ↗

Auf einen Blick

In 35 Einrichtungen ging unter einer regionalen Dekolonisationsstrategie die Prävalenz multiresistenter Organismen zurück. Auch infektiöse Hospitalisierungen, Kosten und Todesfälle nahmen in Pflegeheimen ab.

Fragestellung

Ist die Einführung eines Dekolonisations-Kollaborativs mit geringerem regionalem MDRO-Vorkommen, weniger klinischen Kulturen, weniger infektionsbedingten Hospitalisierungen, Kosten und Todesfällen assoziiert?

Methode

Qualitätsverbesserungsstudie in 35 Einrichtungen in Orange County, Kalifornien, von 1. Juli 2017 bis 31. Juli 2019. Chlorhexidin-Baden und nasale Iodophor-Antisepsis für Bewohner:innen der Langzeitpflege und hospitalisierte Patient:innen unter Kontaktisolation.

Ergebnisse

Unter den teilnehmenden Einrichtungen sank die MDRO-Prävalenz in Pflegeheimen von 63,9 % auf 49,9 %, in LTACHs von 80,0 % auf 53,3 % (OR 0,48; 95 %-KI 0,40–0,57) und bei hospitalisierten Patient:innen in Kontaktisolation von 64,1 % auf 55,4 % (OR 0,75; 95 %-KI 0,60–0,93).

Schlussfolgerung der Autor:innen

Die regionale Zusammenarbeit mit universeller Dekolonisation in Langzeitpflegeeinrichtungen und gezielter Dekolonisation bei hospitalisierten Patient:innen in Kontaktisolation war mit weniger MDRO-Besiedlung, Infektionen, Hospitalisierungen, Kosten und Todesfällen assoziiert.

Kernaussagen

  • MDRO-Prävalenz sank in Pflegeheimen und LTACHs.
  • Hospitalisierte Patient:innen in CP profitierten ebenfalls.
  • In Pflegeheimen nahmen Hospitalisierungen, Kosten und Todesfälle ab.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA, erschienen am 14.05.2024. Verfasst von Gabrielle M Gussin und 38 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of California Irvine School of Medicine, Irvine. Hauptthemen laut MEDLINE: Anti-Infective Agents, Local, Bacterial Infections, Cross Infection, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Infections due to multidrug-resistant organisms (MDROs) are associated with increased morbidity, mortality, length of hospitalization, and health care costs. Regional interventions may be advantageous in mitigating MDROs and associated infections.

Objective

To evaluate whether implementation of a decolonization collaborative is associated with reduced regional MDRO prevalence, incident clinical cultures, infection-related hospitalizations, costs, and deaths. Design, Setting, and Participants This quality improvement study was conducted from July 1, 2017, to July 31, 2019, across 35 health care facilities in Orange County, California. Exposures Chlorhexidine bathing and nasal iodophor antisepsis for residents in long-term care and hospitalized patients in contact precautions (CP). Main Outcomes and Measures Baseline and end of intervention MDRO point prevalence among participating facilities; incident MDRO (nonscreening) clinical cultures among participating and nonparticipating facilities; and infection-related hospitalizations and associated costs and deaths among residents in participating and nonparticipating nursing homes (NHs).

Results

Thirty-five facilities (16 hospitals, 16 NHs, 3 long-term acute care hospitals [LTACHs]) adopted the intervention. Comparing decolonization with baseline periods among participating facilities, the mean (SD) MDRO prevalence decreased from 63.9% (12.2%) to 49.9% (11.3%) among NHs, from 80.0% (7.2%) to 53.3% (13.3%) among LTACHs (odds ratio [OR] for NHs and LTACHs, 0.48; 95% CI, 0.40-0.57), and from 64.1% (8.5%) to 55.4% (13.8%) (OR, 0.75; 95% CI, 0.60-0.93) among hospitalized patients in CP. When comparing decolonization with baseline among NHs, the mean (SD) monthly incident MDRO clinical cultures changed from 2.7 (1.9) to 1.7 (1.1) among participating NHs, from 1.7 (1.4) to 1.5 (1.1) among nonparticipating NHs (group × period interaction reduction, 30.4%; 95% CI, 16.4%-42.1%), from 25.5 (18.6) to 25.0 (15.9) among participating hospitals, from 12.5 (10.1) to 14.3 (10.2) among nonparticipating hospitals (group × period interaction reduction, 12.9%; 95% CI, 3.3%-21.5%), and from 14.8 (8.6) to 8.2 (6.1) among LTACHs (all facilities participating; 22.5% reduction; 95% CI, 4.4%-37.1%). For NHs, the rate of infection-related hospitalizations per 1000 resident-days changed from 2.31 during baseline to 1.94 during intervention among participating NHs, and from 1.90 to 2.03 among nonparticipating NHs (group × period interaction reduction, 26.7%; 95% CI, 19.0%-34.5%). Associated hospitalization costs per 1000 resident-days changed from $64 651 to $55 149 among participating NHs and from $55 151 to $59 327 among nonparticipating NHs (group × period interaction reduction, 26.8%; 95% CI, 26.7%-26.9%). Associated hospitalization deaths per 1000 resident-days changed from 0.29 to 0.25 among participating NHs and from 0.23 to 0.24 among nonparticipating NHs (group × period interaction reduction, 23.7%; 95% CI, 4.5%-43.0%). Conclusions and Relevance A regional collaborative involving universal decolonization in long-term care facilities and targeted decolonization among hospital patients in CP was associated with lower MDRO carriage, infections, hospitalizations, costs, and deaths.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective Agents, LocalBacterial InfectionsCross InfectionDrug Resistance, Multiple, BacterialHealth FacilitiesInfection ControlAgedHumansAdministration, IntranasalBathsCaliforniaChlorhexidineHospitalizationHospitalsIodophorsNursing HomesPatient TransferQuality ImprovementSkin CareUniversal Precautions

Substanzen

Anti-Infective Agents, LocalChlorhexidineIodophors

Autor:innen und Institutionen

  • Division of Infectious Diseases, University of California Irvine School of Medicine, Irvine.
  • Division of Infectious Diseases, Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California.
  • Program in Biostatistics, University of Massachusetts Amherst School of Public Health and Health Sciences, Amherst.
  • Healthcare-Associated Infections Program, Center for Healthcare Quality, California Department of Public Health, Richmond.
  • Epidemiology and Assessment, Orange County Health Care Agency, Santa Ana, California.
  • Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.

Zitieren

APA

Gussin, G. M., McKinnell, J. A., Singh, R. D., Miller, L. G., Kleinman, K., Saavedra, R., Tjoa, T., Gohil, S. K., Catuna, T. D., Heim, L. T., Chang, J., Estevez, M., He, J., O'Donnell, K., Zahn, M., Lee, E., Berman, C., Nguyen, J., Agrawal, S., …, & CDC Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program (2024). Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes. JAMA, 331(18), 1544. https://doi.org/10.1001/jama.2024.2759

Vancouver

Gussin GM, McKinnell JA, Singh RD, Miller LG, Kleinman K, Saavedra R, et al. Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes. JAMA. 2024;331(18):1544. doi:10.1001/jama.2024.2759

BibTeX
@article{Gussin2024,
  author = {Gussin, Gabrielle M and McKinnell, James A and Singh, Raveena D and Miller, Loren G and Kleinman, Ken and Saavedra, Raheeb and Tjoa, Thomas and Gohil, Shruti K and Catuna, Tabitha D and Heim, Lauren T and Chang, Justin and Estevez, Marlene and He, Jiayi and O'Donnell, Kathleen and Zahn, Matthew and Lee, Eunjung and Berman, Chase and Nguyen, Jenny and Agrawal, Shalini and Ashbaugh, Isabel and Nedelcu, Christine and Robinson, Philip A and Tam, Steven and Park, Steven and Evans, Kaye D and Shimabukuro, Julie A and Lee, Bruce Y and Fonda, Emily and Jernigan, John A and Slayton, Rachel B and Stone, Nimalie D and Janssen, Lynn and Weinstein, Robert A and Hayden, Mary K and Lin, Michael Y and Peterson, Ellena M and Bittencourt, Cassiana E and Huang, Susan S and CDC Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program, CDC Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program},
  title = {Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes},
  journal = {JAMA},
  year = {2024},
  volume = {331},
  number = {18},
  pages = {1544},
  doi = {10.1001/jama.2024.2759}
}
Kostenlos starten →